emend

Generic: aprepitant

Labeler: merck sharp & dohme llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name emend
Generic Name aprepitant
Labeler merck sharp & dohme llc
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

aprepitant 125 mg/1

Manufacturer
Merck Sharp & Dohme LLC

Identifiers & Regulatory

Product NDC 0006-3066
Product ID 0006-3066_428f7828-6d1c-438b-a17d-b4af0700c740
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA207865
Listing Expiration 2026-12-31
Marketing Start 2015-12-17

Pharmacologic Class

Established (EPC)
substance p/neurokinin-1 receptor antagonist [epc]
Mechanism of Action
neurokinin 1 antagonists [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00063066
Hyphenated Format 0006-3066

Supplemental Identifiers

RxCUI
403810 403811 404465 404466 644088 644278 754508 754509 1729308 1729311
UNII
1NF15YR6UY
NUI
N0000010262 N0000175786 N0000182141 N0000185507 N0000185506

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name emend (source: ndc)
Generic Name aprepitant (source: ndc)
Application Number NDA207865 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 125 mg/1
source: ndc
Packaging
  • 1 POUCH in 1 CARTON (0006-3066-03) / 1 POWDER, FOR SUSPENSION in 1 POUCH (0006-3066-01)
source: ndc

Packages (1)

0006-3066-03 1 POUCH in 1 CARTON (0006-3066-03) / 1 POWDER, FOR SUSPENSION in 1 POUCH (0006-3066-01)

Ingredients (1)

aprepitant (125 mg/1)

Linked Drug Pages (1)

EMEND ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "428f7828-6d1c-438b-a17d-b4af0700c740", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "unii": ["1NF15YR6UY"], "rxcui": ["403810", "403811", "404465", "404466", "644088", "644278", "754508", "754509", "1729308", "1729311"], "spl_set_id": ["696f9e80-9cae-403b-de9e-078343ce4713"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (0006-3066-03)  / 1 POWDER, FOR SUSPENSION in 1 POUCH (0006-3066-01)", "package_ndc": "0006-3066-03", "marketing_start_date": "20151217"}], "brand_name": "EMEND", "product_id": "0006-3066_428f7828-6d1c-438b-a17d-b4af0700c740", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "0006-3066", "generic_name": "aprepitant", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMEND", "active_ingredients": [{"name": "APREPITANT", "strength": "125 mg/1"}], "application_number": "NDA207865", "marketing_category": "NDA", "marketing_start_date": "20151217", "listing_expiration_date": "20261231"}